Posted on 09/21/2021 2:07:07 PM PDT by Titus-Maximus
Sept. 21 (UPI) -- Treatment with monoclonal antibodies reduced the need for hospital care in adults at high risk for serious illness from COVID-19, a study published Tuesday by JAMA Network Open found.
Just over 17% of high-risk Native Americans given the treatment based on laboratory-created antibodies, or immune proteins that fight off infections, within days of testing positive for the virus were admitted to the hospital, the data showed.
However, 43% of patients in the study who did not receive monoclonal antibodies required hospital treatment.
In addition, more than 4% of the untreated patients were admitted to a hospital intensive care unit because of COVID-19, and nearly 3% died from the disease.
None of the patients given monoclonal antibodies were admitted to the ICU and none died, they said.
Thats probably because he got a false positive reading. Was he acting sick? Lost taste smell all that jazz? These tests like the shot don’t work either.
No, he actually had it. Lost of taste and smell which has now came back.
Is stepson in Texas or Florida?
Florida.
Do line up a hospital which is willing to administer this treatment.
My husband and I got our treatment last April at an urgent care facility. The doctor that administered mine told me they had a warehouse full. He was hoping more patients would come in for the treatment. We went in for a covid test, tested positive and were able to set up an appointment for the monoclonal treatment the next day. This was in Michigan.
IV infusion. They said it takes an hour to infuse and a couple hours of observation after.
Monoclonal antibodies are difficult to produce and . . . (drumroll) . . . are extremely expensive:
The cost of Regeneron’s two-drug cocktail is $1,250 per infusion, according to Kaiser Health News. If there is a big demand for it, that cost will go higher. And, you will be put on a waiting list to get it.
Budisonide is good to have on hand.
https://www.inhousepharmacy.vu/search.aspx?searchterm=Budisonide
Have had no problems ordering from them. No cards they only take checks.
TY.
There is no cost to the patient to get the therapy. It is life saving. If diagnosed with covid do not delay seeking it out
It’s can be either 4 shots or an IV infusion. The folks that i know that have taken the monoclonal treatment said they had 4 shots….1 in each arm and 1 on each side of their stomachs. It’s quicker and was effective for them.
Makes sense; I’d opt for the quick shots.
For those of us over 71, and with 5 co-morbidities, that’s not an option.
The antibodies do not contain the spiked protein, which the vaccines do.
Why can’t they try Ivermectin, it works well in India and Africa.
Which inhaler did you buy?
https://www.inhousepharmacy.vu/ Sure seems a lot less expensive than getting in the states.
Budesonide (Pulmicort) (Flexhaler): [180 mcg/inhalation, 120 inhalations costs $250] Usual dose for asthma is 1-2 puffs BID but if give 4 INH BID x 14 days = 124 doses.
• A multicentre, open-label, multi-arm, randomised, controlled trial shows that inhaled budesonide (800 μg twice daily for 14 days) for patients in the community with suspected COVID-19 and at high risk of complications was associated with improved time to recovery and a reduced chance of hospitalization compared with patients who received usual care (Lancet 2021 Aug 10;EPub Ahead of Print). Eligible participants were aged 65 years or older or 50 years or older with comorbidities ( such as cancer, diabetes, cardiovascular or lung disease, or obesity), and unwell for up to 14 days (average, 6 days) with suspected COVID-19 but not admitted to hospital. There was a benefit in time to first self-reported recovery of an estimated 3 days in the budesonide group versus the usual care group (11.8 days vs 14.7 days). For the hospital admission or death outcome, the estimated rate was 6·8% in the budesonide group versus 8·8% in the usual care group (estimated absolute difference 2.0%). Editorialist notes that ICS is a simple and inexpensive option with little apparent downside, and offering it to select higher-risk patients (similar to those in this trial) would be reasonable.
Thanks
“For those of us over 71, and with 5 co-morbidities, that’s not an option.”
??? From what I understand, if you get covid, monoclonal antibodies ARE an option for you! Why do you say they are not?
I’ll be dead by the time I get to the ER to get dosed.
“I’ll be dead by the time I get to the ER to get dosed.”
THAT’s why you are preparing and taking precautions-—for a just in case you get a sniffle.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.